Right atrial myxoma as the first manifestation of granulomatosis with polyangiitis, and a possible association with vascular endothelial growth factor (VEGF) and interleukin 6 (IL-6): a case report and review of the literature

Kumar V, Abbas AK, Aster JC, Perkins JA. Robbins and Cotran pathologic basis of disease; 2015. McGeoch L, Carette S, Cuthbertson D, Hoffman GS, Khalidi N, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, et al. Cardiac involvement in granulomatosis with polyangiitis. J Rheumatol. 2015;42(7):1209–12. Morelli S, Di Castelmenardo AG, Conti F, Sgreccia A, Alessandri C, Bernardo ML, Valesini G. Cardiac involvement in patients with Wegener’s granulomatosis. Rheumatol Int. 2000;19(6):209–12. Pugnet G, Gouya H, Puéchal X, Terrier B, Kahan A, Legmann P, Guillevin L, Vignaux O. Group obotFVS: Cardiac involvement in granulomatosis with polyangiitis: a magnetic resonance imaging study of 31 consecutive patients. Rheumatology. 2017;56(6):947–56. Ruisi M, Ruisi P, Finkielstein D. Cardiac manifestations of Wegener’s granulomatosis: case report and review of the literature. J Cardiol Cases. 2010;2(2):e99–102. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine. 2001;80(3):159–72. Ishiguro T, Takayanagi N, Kawate E, Takaku Y, Kagiyama N, Shimizu Y, Yanagisawa T, Sugita Y. Development of multi-organ involvement including a left atrial myxoma-like lesion in a patient with granulomatosis with polyangiitis. Int Med. 2014;53(11):1143–7. Mortazavi M, Nasri H. Granulomatosis with polyangiitis (Wegener’s) presenting as the right ventricular masses: a case report and review of the literature. J Nephropathol. 2012;1(1):49–56. Herbst A, Padilla MT, Prasad AR, Morales MC, Copeland JG. Cardiac Wegener’s granulomatosis masquerading as left atrial myxoma. Ann Thorac Surg. 2003;75(4):1321–3. Li CG, Reynolds I, Ponting JM, Holt PJ, Hillarby MC, Kumar S. Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener’s granulomatosis. Br J Rheumatol. 1998;37(12):1303–6. Sakamoto H, Sakamaki T, Kanda T, Tsuchiya Y, Sato M, Sato H, Oyama Y, Sawada Y, Tamura J, Nagai R, et al. Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J. 2004;68(5):488–93. Kono T, Koide N, Hama Y, Kitahara H, Nakano H, Suzuki J, Isobe M, Amano J. Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: a study of fifteen patients. J Thorac Cardiovasc Surg. 2000;119(1):101–7. Sun B, Liang LF, Li J, Yang D, Zhao XB, Zhang KG. A meta-analysis of interleukin-6 as a valid and accurate index in diagnosing early neonatal sepsis. Int Wound J. 2019;16(2):527–33. Krajewska Wojciechowska J, Kościelska-Kasprzak K, Krajewski W, Morawski K. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings. Eur Cytokine Netw. 2019;30(4):151–9. Mendoza CE, Rosado MF, Bernal L. The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence. Tex Heart Inst J. 2001;28(1):3–7. Ezerioha N, Feng W. Intracardiac myxoma, cerebral aneurysms and elevated interleukin-6. Case Rep Neurol. 2015;7(2):152–5. Amano J, Kono T, Wada Y, Zhang T, Koide N, Fujimori M, Ito K. Cardiac myxoma: its origin and tumor characteristics. Ann Thorac Cardiovasc Surg. 2003;9(4):215–21. Di Vito A, Mignogna C, Donato G. The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathology. Histopathology. 2015;66(3):321–32. Oliveira GH, Seward JB, Tsang TS, Specks U. Echocardiographic findings in patients with Wegener granulomatosis. Mayo Clin Proc. 2005;80(11):1435–40. Życińska K, Borowiec A, Zielonka TM, Rusinowicz T, Hadzik-Błaszczyk M, Cieplak M, Wardyn KA. Echocardiographic assessment in patients with granulomatosis with polyangiitis. Adv Exp Med Biol. 2017;1022:27–33.